Article
Clinical Impact of Hybrid Capture-Based Next-Generation Sequencing on Changes in Treatment Decisions in Lung Cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Feb 2017
Rozenblum Anna Belilovski, Ilouze Maya, Dudnik Elizabeth, Dvir Addie, Soussan-Gutman Lior, Geva Smadar, Peled Nir
Abstract excerpt
INTRODUCTION: Targeted therapy significantly prolongs survival in lung adenocarcinoma. Current diagnostic guidelines include only EGFR and anaplastic lymphoma receptor tyrosine kinase gene (ALK) testing. Next-generation sequencing (NGS) reveals more actionable genomic alterations than do standard diagnostic methods. Data on the influence of hybrid capture (HC)-based NGS on treatment are limited, and we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
